GLP-1 receptor agonists lead a new wave of therapeutic options that may benefit patients with osteoarthritis, according to ...

This 3-part series looks at the current evidence for the treatment of SUD, alcohol use disorder, and tobacco use disorder.

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...

Efficacy of tirzepatide does not differ significantly between men and women, despite sex-specific differences in ...

GLP-1 receptor agonists have long half-lives so a patient would need to stop taking it a month before a scan for it to completely eliminate the risk of it influencing the imaging. Gadaleta noted that ...

Researchers at Ruhr University Bochum, Germany, identified a receptor that plays a crucial role in stress-induced motor ...

Researchers at Leipzig University and Martin Luther University Halle-Wittenberg have investigated a previously unknown ...

Drugs.com has explained the side effects of popular weight loss drugs as doctors issue a fresh warning over an ‘unusual’ ...

Anti-obesity drugs such as semaglutide (Ozempic, Wegovy) are also promising for the treatment of alcohol use disorder and alcohol-associated liver disease, as growing evidence suggests they reduce the ...

This 3-part series looks at the evidence for the treatment of SUDs reviews & the use of GLP-1 receptor agonists and alcohol use disorder.

People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems.

When it comes to brain proteins, small changes can make a dramatic difference. Researchers studying NMDA ...